Abstract:Background Survivin is a member of the inhibitors of apoptosis protein family, is expressed in most of human cancers. Thus, we hypothesized that using a survivin promoter-driven vector system, an apoptosis-inducible gene may be preferentially restricted to survivin-positive tumor cells. PUMA (p53 upregulated modulator of apoptosis) was recently identified a potent proapoptotic molecule. In the present study, our aim is to investigate whether adenovirus-mediated PUMA gene transfer using the survivin promoter could specifically enhance radiosensitivity of breast cancer cells in vitro and in vivo. Materials and methods Firstly, we performed RT-PCR assay to detect survivin mRNA expression in four human breast cancer cell lines and two normal cell lines. Then, we constructed plasmid vectors expressing luciferase or EGFP reporter gene driven by the survivin core promoter and evaluated its transcriptional activity in vitro. Next, a survivin promoter-driven adenoviral system expressing PUMA gene was constructed. Western blotting analysis of PUMA protein expression in MCF-7 and MCF210 cells treated with various adenovirus (empty, driven by CMV promoter or survivin promoter). Followingly, the effects of PUMA overexpression on the in vitro radiosensitivity of breast cancer cells were investigated by clonogenic formation assay. Cellular apoptosis were determined by FCM and TUNEL assays. The expression and activities of cellular caspase-3 were assayed by Western blot and colorimetry. Finally, we investigated the effect of PUMA overexpression on the radiosensitivity of breast carcinoma cells in vivo. Results The survivin mRNA expression was obviously upregulated in breast cancer cell lines but in normal cell lines. Moreover, the survivin promoter could drive high-level expression of luciferase or EGFP in breast cells but not in normal cells. Using a survivin promoter-driven adenoviral system expressing PUMA gene, we found that PUMA expression was specifically and efficiently induced in MCF-7 cell but not in MCF210 cell. Furthermore, we observed that the novel adenovirus system could significantly enhance radiosensitivity of MCF-7 cell in vitro and in vivo, which might be associated with apoptosis induction by activating cellular caspase-3. Conclusion Our findings indicated that the survivin promoter-driven adenovirus system expression PUMA gene might be explored as a potential tool for radiosensitization of human breast cancer cells with tumor specificity and high efficacy.

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

Survioin promoter activity in tumor cell lines

Antitumor Potential of SLPI Promoter Controlled Recombinant Caspase-3 Expression in Laryngeal Carcinoma

Survivin Promoter and Tumor

Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo

Lentivirus-mediated Gene Therapy by Suppressing Survivin in BALB/c Nude Mice Bearing Oral Squamous Cell Carcinoma.

Improved Radiotherapy by Survivin Small Hairpin RNA Trigger Apoptosis of Human Lung Adenocarcinoma Via Caspase-3 Upregulation in Vitro and in Vivo

[Effects of Human Telomerase Reverse Transcriptase Promoter and Survivin Promoter in Targeted Tumor Gene Therapy].

Lentivirus-mediated Shrna Targeting XIAP and Survivin Inhibit SW1990 Pancreatic Cancer Cell Proliferation in Vitro and in Vivo.

Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant

Cloning of survivin promoter and its specific transcriptional activities in gastric cancer cell line AGS

An Experimental Study on Targeting Suicide Gene Therapy for Lung Cancer with HSV-TK Driven by hTERT Promoter

Expression of exogenous Muc1,Survivin and Nanog gene promoters in colon cancer stem cells

Cloning and identification of survivin gene promoter segments with different activities

Tumor-specific transcriptional targeting of suicide gene therapy

Inhibition of lymphatic metastases by a survivin dominant-negative mutant

Construction of Survivin Specific Small Interfering RNA Expression Vector,its Antiproliferative and Proapoptotic Effect on Lung Adenocarcinoma Cells

Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect

[Inhibition Function of Dominant-negative Mutant Gene Survivin-D53A to SPC-A1 Lung Adenocarcinoma Xenograft in Nude Mice Models].

Preliminary Study of Cell Cycle Specific Survivin Promotor Activity in Glioblastoma Cell Line

Construction of a Novel Vector Expressing Survivin-shRNA and Fusion Suicide Gene Ycdglytk and Its Application in Inhibiting Proliferation and Migration of Colon Cancer Cells